Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combination of oxidative phosphorylation and platelet-derived growth factor inhibitors for the treatment of ovarian cancers.

npj women's health·2026
Same author

Cracking the code: predicting tumor microenvironment enabled chemoresistance with machine learning in the human tumoroid models.

npj biomedical innovations·2026
Same author

Assessment of a standard dietitian evaluation in pediatric patients with celiac disease.

Nutrition (Burbank, Los Angeles County, Calif.)·2026
Same author

Tumoroid model recreates clinically relevant phenotypes of high grade serous ovarian cancer cells, carcinoma associated fibroblasts, and macrophages.

Acta biomaterialia·2026
Same author

Improving pediatric inflammatory bowel disease outcomes through social determinants of health interventions.

Journal of pediatric gastroenterology and nutrition·2026
Same author

Phosphoproteomic identification of Mos-MAPK targets in meiotic cell cycle and asymmetric oocyte divisions.

The Journal of cell biology·2025

Related Experiment Video

Updated: May 12, 2025

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

6.8K

Cracking the Code: Predicting Tumor Microenvironment Enabled Chemoresistance with Machine Learning in the Human

Geeta Mehta1, Michael Bregenzer1, Pooja Mehta1

  • 1University of Michigan.

Research Square
|May 2, 2025
PubMed
Summary

Tumor microenvironment cellular composition in high-grade serous tubo-ovarian cancer (HGSC) impacts drug response. Understanding this diversity can predict treatment efficacy and guide future ovarian cancer therapies.

Keywords:
HGSCcell compositionchemoresistancedrug responsehigh grade serous carcinomamolecular subtypeorganoidovarian cancersspheroids

More Related Videos

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.5K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Related Experiment Videos

Last Updated: May 12, 2025

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
09:53

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

6.8K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.5K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Area of Science:

  • Oncology
  • Cancer Biology
  • Genomics

Background:

  • High-grade serous tubo-ovarian cancer (HGSC) exhibits significant inter- and intra-tumor heterogeneity.
  • Variability in tumor microenvironments (TME) across metastatic sites correlates with poorer patient outcomes.
  • The impact of cellular composition on therapy sensitivity in HGSC remains underexplored.

Purpose of the Study:

  • To investigate if variations in cellular composition can predict drug efficacy in HGSC.
  • To analyze the influence of TME cellular makeup on treatment responses.
  • To establish a foundation for using human tumoroids to study TME-mediated chemoresistance.

Main Methods:

  • Utilized a high-throughput 3D in vitro tumoroid model.
  • Assessed drug responses of 23 distinct cellular configurations to five therapeutic agents, including carboplatin and paclitaxel.
  • Employed random forest machine learning algorithms to correlate TME composition with treatment reactions.

Main Results:

  • Observed significant disparities in drug responses linked to tumoroid composition.
  • Demonstrated that TME cellular diversity is a significant predictor of therapeutic outcomes.
  • Highlighted the complex relationship between cell composition and drug response.

Conclusions:

  • TME cellular composition is a crucial factor influencing therapeutic outcomes in HGSC.
  • Human tumoroids with varied cellular composition offer a platform to study TME roles in treatment susceptibility and chemoresistance.
  • Further research into TME cellular interactions is vital for understanding and overcoming chemoresistance and cancer recurrence.